| Aktie | Ticker | Breite | GCS | 2025/Q4 | |||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 72.368.189 $ | +72.368.189 $ | 3 | |||||
| Beam Therapeutics Inc. | BEAM | → 0 | Neutral | 35.119.410 $ | +35.119.410 $ | 1 | |
| Lyell Immunopharma, Inc. | LYEL | → 0 | Neutral | 31.029.810 $ | +31.029.810 $ | 1 | |
| Prime Medicine, Inc. | PRME | → 0 | Schwach | 6.218.969 $ | +6.218.969 $ | 1 | |
| 72.368.189 $ | +72.368.189 $ | 3 | |||||